Financials
Financial year 2025
PHARMBIOSOL from Liège, company number BE0599848790, closed financial year 2025 with a result of € -16,970 after tax. For that financial year PHARMBIOSOL recorded a gross margin of € -2,487 and equity of € 20,840. Compared with financial year 2024, the result moved from € 1,204 to € -16,970. The company made a loss. The buffer shrank hard: equity is 52 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.
€ 20,840
▼ 52% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -16,970
▼ still € 1,204 profit in 2024
Profit after tax over the fiscal year.
€ 18,532
▼ 33% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 2,240.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 15,709
▼ 33% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 6,400
Loans from banks and other lenders, long and short.
€ 960
▲ 42% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,093
▲ € 5,121 vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,814 | € 27,806 | € 11,240 | € -2,487 | ▼ € 13,728 |
| Profit after taxes | € -1,132 | € 14,127 | € 1,204 | € -16,970 | ▼ € 18,174 |
| Equity | € 32,979 | € 42,106 | € 43,310 | € 20,840 | ▼ 52% |
| Total debts | € 5,791 | € 42,800 | € 22,600 | € 26,419 | ▲ 17% |
| Cash | € 12,811 | € 28,090 | € 27,859 | € 18,532 | ▼ 33% |
| Retained profit | € 14,379 | € 23,506 | € 24,710 | € 2,240 | ▼ 91% |
| Dividend | € 0 | € 5,000 | € 0 | € 5,500 | |
| Bank debt | € 0 | € 6,400 | € 6,400 | € 6,400 | |
| Balance sheet total | € 38,770 | € 84,906 | € 65,910 | € 47,259 | ▼ 28% |
Key figures of PHARMBIOSOL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMBIOSOL?
What happened at PHARMBIOSOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 16,970 (▼ € 18,174 vs 2024). Source: NBB ↗
- Sabine OLIVIER became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,132 loss in 2022 to € 16,970 loss in 2025.
Paid € 4,696 in corporate taxes since 2022.
Best year ever: 2023, with € 14,127 profit.
Paid out € 10,500 in dividends to the owners in total.
A new publication or filing at PHARMBIOSOL? We notify you, reason included.
Follow PHARMBIOSOLDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Sabine OLIVIER
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Rue Saint-Laurent 313
4000 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0599.848.790
- VAT number
- BE 0599.848.790
- Registered office
- Rue Saint-Laurent 313, 4000 Liège
- Names & denominations
- PHARMBIOSOL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 March 2015
- Peppol
- Active · Active since 3 Nov 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts